Trump downplays recent missile launches by North Korea

Agencies

July 26, 2019

Washington DC, Jul 26: United States President Donald Trump has downplayed the recent missile launches by North Korea, saying that they tested a "smaller missile" which is something that a lot of countries do.

In an interview to Fox News on Thursday night (local time), as cited by Sputnik News Agency, Trump pointed out that North Korea has not carried out "nuclear testing", and that Washington and Pyongyang have been "doing very well."

"In the case of North Korea, I am actually getting along very well with [Kim]. But we'll see what happens. The sanctions are on. The hostages are back. We're getting the remains back. They haven't done nuclear testing," said Trump

"They really haven't tested missiles other than, you know, smaller ones, which is something that lots test. But I think with North Korea, we've been doing very well", he added.

North Korea on Thursday fired two-short range ballistic missiles into the East Sea. A day later, the country fired its "new tactical guided weapon" under leader Kim Jong-un's guidance in a demonstration of power, the state media reported, adding that the firings were aimed at sending "stern warning to the South Korean military rebels."

The launches came less than a month after Trump and Kim held a surprise meeting at the inter-Korean border village of Panmunjom and agreed to resume working-level nuclear negotiations.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments